What is the current Price Target for the Tyra Bioscience stock?

The average Tyra Bioscience target price is $30.60. This is 148.58% higher than the current stock price. The highest price target is 181.48%, the lowest is 129.73%. 9 Analysts have issued a price target Tyra Bioscience 2026 .

How high will the Tyra Bioscience stock rise?

No reliable answer can be given as to how high the Tyra Bioscience stock will rise. The performance of stocks, including the Tyra Bioscience stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Tyra Bioscience stock today?

The performance of Tyra Bioscience stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Tyra Bioscience stock fall?

The decline in Tyra Bioscience stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Tyra Bioscience Forecast, price target & analysts

$12.31

1.68% yesterday

NYSE, Sep 15, 10:11 pm CET

ISIN

US90240B1061

Symbol

TYRA

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Tyra Bioscience Target price 2025 - Analyst rating & recommendation

Tyra Bioscience Classifications & Recommendation:

Buy

93%

Hold

Tyra Bioscience Price Target

Target Price	$30.60
Price	$12.31
Potential	148.58% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Tyra Bioscience 2026 . The average Tyra Bioscience target price is $30.60. This is 148.58% register free of charge higher than the current stock price. The highest price target is $34.65 181.48% register free of charge , the lowest is $28.28 129.73% register free of charge .
	A rating was issued by 14 analysts: 13 Analysts recommend Tyra Bioscience to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Tyra Bioscience stock has an average upside potential 2026 of 148.58% register free of charge . Most analysts recommend the Tyra Bioscience stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.51	-2.05
	6.79%	35.76%
P/E		negative

10 Analysts have issued a Tyra Bioscience forecast for earnings per share. The average Tyra Bioscience EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.51	6.79%
2025	$-2.05 35.76% Unlock
2026	$-2.30 12.20% Unlock
2027	$-2.50 8.70% Unlock
2028	$-1.18 52.80% Unlock
2029	$1.92 262.71% Unlock
2030	$7.08 268.75% Unlock
2031	$15.91 124.72% Unlock
2032	$26.58 67.06% Unlock

Current	-6.88	55.64%
2025	-6.01 12.61% Unlock
2026	-5.34 11.15% Unlock
2027	-4.93 7.68% Unlock
2028	-10.40 110.95% Unlock
2029	6.42 161.73% Unlock
2030	1.74 72.90% Unlock
2031	0.77 55.75% Unlock
2032	0.46 40.26% Unlock

Tyra Bioscience...

Current Tyra Bioscience Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Raymond James	Locked ➜ Locked	Locked	Sep 03 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 22 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 31 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 18 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 13 2025
UBS	Locked ➜ Locked	Locked	Jan 07 2025

Analyst Rating	Date
Locked Raymond James: Locked ➜ Locked	Sep 03 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 22 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 31 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 18 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 13 2025
Locked UBS: Locked ➜ Locked	Jan 07 2025

Discover more stocks with a high price target

Novo Nordisk 43.62%

BioNTech SE - ADR 42.25%

Deutsche Telekom 29.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now